179 related articles for article (PubMed ID: 15504403)
21. Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2.
Stahelin RV; Cho W
Biochemistry; 2001 Apr; 40(15):4672-8. PubMed ID: 11294634
[TBL] [Abstract][Full Text] [Related]
22. Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein.
Weiss J; Wright G; Bekkers AC; van den Bergh CJ; Verheij HM
J Biol Chem; 1991 Mar; 266(7):4162-7. PubMed ID: 1999411
[TBL] [Abstract][Full Text] [Related]
23. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of a porcine pancreatic phospholipase A2 mutant. A large conformational change caused by the F63V point mutation.
Thunnissen MM; Franken PA; de Haas GH; Drenth J; Kalk KH; Verheij HM; Dijkstra BW
J Mol Biol; 1993 Aug; 232(3):839-55. PubMed ID: 8355274
[TBL] [Abstract][Full Text] [Related]
25. Targeting of porcine pancreatic phospholipase A2 to human platelets. Introduction of an RGD sequence and acyl-group by chemical modification.
Bekkers AC; Slotboom AJ; van Willigen G; Akkerman JW; Verheij HM
Eur J Biochem; 1996 May; 238(1):70-6. PubMed ID: 8665954
[TBL] [Abstract][Full Text] [Related]
26. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
Johnson JE; Rao NM; Hui SW; Cornell RB
Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
[TBL] [Abstract][Full Text] [Related]
27. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
[TBL] [Abstract][Full Text] [Related]
28. Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.
Snitko Y; Koduri RS; Han SK; Othman R; Baker SF; Molini BJ; Wilton DC; Gelb MH; Cho W
Biochemistry; 1997 Nov; 36(47):14325-33. PubMed ID: 9398150
[TBL] [Abstract][Full Text] [Related]
29. A Fourier transform infrared spectroscopic (FTIR) study of porcine and bovine pancreatic phospholipase A2 and their interaction with substrate analogues and a transition-state inhibitor.
Kennedy DF; Slotboom AJ; de Haas GH; Chapman D
Biochim Biophys Acta; 1990 Sep; 1040(3):317-26. PubMed ID: 2223837
[TBL] [Abstract][Full Text] [Related]
30. A molecular model for interfacial activation in phospholipase A2.
Warwicker J
FEBS Lett; 1997 Mar; 404(2-3):159-63. PubMed ID: 9119055
[TBL] [Abstract][Full Text] [Related]
31. Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99.
Sekar K; Yu BZ; Rogers J; Lutton J; Liu X; Chen X; Tsai MD; Jain MK; Sundaralingam M
Biochemistry; 1997 Mar; 36(11):3104-14. PubMed ID: 9115986
[TBL] [Abstract][Full Text] [Related]
32. Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.
Singh N; Jabeen T; Pal A; Sharma S; Perbandt M; Betzel C; Singh TP
Proteins; 2006 Jul; 64(1):89-100. PubMed ID: 16596639
[TBL] [Abstract][Full Text] [Related]
33. Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2.
Xu GY; McDonagh T; Yu HA; Nalefski EA; Clark JD; Cumming DA
J Mol Biol; 1998 Jul; 280(3):485-500. PubMed ID: 9665851
[TBL] [Abstract][Full Text] [Related]
34. Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2.
Beers SA; Buckland AG; Giles N; Gelb MH; Wilton DC
Biochemistry; 2003 Jun; 42(24):7326-38. PubMed ID: 12809488
[TBL] [Abstract][Full Text] [Related]
35. 1H, 15N and 13C resonance assignments and secondary structure of group II phospholipase A2 from Agkistrodon piscivorus piscivorus: presence of an amino-terminal helix in solution.
Jerala R; Almeida PF; Ye Q; Biltonen RL; Rule GS
J Biomol NMR; 1996 Mar; 7(2):107-20. PubMed ID: 8616268
[TBL] [Abstract][Full Text] [Related]
36. Phospholipid binding and the activation of group IA secreted phospholipase A2.
Boegeman SC; Deems RA; Dennis EA
Biochemistry; 2004 Apr; 43(13):3907-16. PubMed ID: 15049698
[TBL] [Abstract][Full Text] [Related]
37. Atomic resolution structure of prokaryotic phospholipase A2: analysis of internal motion and implication for a catalytic mechanism.
Matoba Y; Sugiyama M
Proteins; 2003 May; 51(3):453-69. PubMed ID: 12696056
[TBL] [Abstract][Full Text] [Related]
38. Suggestive evidence for the involvement of the second calcium and surface loop in interfacial binding: monoclinic and trigonal crystal structures of a quadruple mutant of phospholipase A2.
Sekar K; Yogavel M; Kanaujia SP; Sharma A; Velmurugan D; Poi MJ; Dauter Z; Tsai MD
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):717-24. PubMed ID: 16790927
[TBL] [Abstract][Full Text] [Related]
39. Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2.
Hixon MS; Ball A; Gelb MH
Biochemistry; 1998 Jun; 37(23):8516-26. PubMed ID: 9622504
[TBL] [Abstract][Full Text] [Related]
40. Contributions of residues of pancreatic phospholipase A2 to interfacial binding, catalysis, and activation.
Yu BZ; Rogers J; Tsai MD; Pidgeon C; Jain MK
Biochemistry; 1999 Apr; 38(15):4875-84. PubMed ID: 10200177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
